{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:25:08Z","timestamp":1787757908528,"version":"build-2784847793"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Individuals who have shown recovery from coronavirus disease (COVID-19) are increasingly getting diagnosed with Mucormycosis or \u201cBlack fungus.\u201d It is a difficult condition to diagnose as it has symptoms that are common among a variety of diseases. Hence, it is important to identify the presenting signs and understand the underlying pathogenesis of COVID-19 associated Mucormycosis. The incidence of these mycotic infections has shown a substantial increase in current times owing to an increase in the prevalence of immunocompromised subjects, human immunodeficiency virus (HIV) infection, and acquired immunodeficiency syndrome (AIDS). Any suspected case of mucormycosis requires rapid diagnosis and management due to its rapid progression as well as the destructive course of infection. This article reviews the taxonomy, pathogenesis, and clinical signs along with laboratory investigations that may play a vital role in the timely diagnosis of this condition as it is mostly fatal.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_1599_21","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T07:41:10Z","timestamp":1653464470000},"page":"1672-1676","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Oral Mucormycosis"],"prefix":"10.4103","volume":"11","author":[{"given":"Madhura Dattatraya","family":"Kulkarni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saakshi","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivangi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Sabharwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadish P.","family":"Rajguru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abishek","family":"Baneerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20240828","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19:A systematic review of cases reported worldwide and in India","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"R2-13-20240828","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/CMR.13.2.236","article-title":"Zygomycetes in human disease","volume":"13","author":"Ribes","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"R3-13-20240828","first-page":"243","article-title":"Pulmonary defense mechanisms against opportunistic fungal pathogens","volume":"47","author":"Waldorf","year":"1989","journal-title":"Immunol Ser"},{"key":"R4-13-20240828","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1172\/JCI111395","article-title":"Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense mechanisms against Rhizopus","volume":"74","author":"Waldorf","year":"1984","journal-title":"JClin Invest"},{"key":"R5-13-20240828","first-page":"76","article-title":"Attachment of spores of the human pathogenic fungus Rhizopus oryzae to extracellular matrix components","volume":"70","author":"Bouchara","year":"1996","journal-title":"Eur J Cell Biol"},{"key":"R6-13-20240828","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission diagnosis, and treatment of coronavirus disease 2019 (COVID-19):A review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"key":"R7-13-20240828","doi-asserted-by":"crossref","first-page":"867","DOI":"10.18203\/issn.2454-5929.ijohns20211583","article-title":"A case series of invasive mucormycosis in patients with COVID-19 infection","volume":"7","author":"Mishra","year":"2021","journal-title":"Int J Otorhinolaryngol Head Neck Surg"},{"key":"R8-13-20240828","doi-asserted-by":"crossref","first-page":"85","DOI":"10.14740\/jmc3637","article-title":"Rhinocerebral mucormycosis and COVID-19 pneumonia","volume":"12","author":"Alekseyev","year":"2021","journal-title":"J Med Cases"},{"key":"R9-13-20240828","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.diabet.2012.01.002","article-title":"Diabetes and mucormycosis:A complex interplay","volume":"38","author":"Rammaert","year":"2012","journal-title":"Diabetes Metab"},{"key":"R10-13-20240828","first-page":"e4295","article-title":"Rhinooculo cerebral mucormycosis resistant to amphotericin B in a young patient with diabetic ketoacidosis","volume":"11","author":"Ali Asghar","year":"2019","journal-title":"Cureus"},{"key":"R11-13-20240828","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1177\/1060028016655425","article-title":"Breaking the mold:A review of mucormycosis and current pharmacological treatment options","volume":"50","author":"Riley","year":"2016","journal-title":"Ann Pharmacother"},{"key":"R12-13-20240828","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis:An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"R13-13-20240828","doi-asserted-by":"crossref","first-page":"135","DOI":"10.18231\/j.achr.2021.033","article-title":"Invasive mucormycosis in post-COVID-19 infection:Case report with review","volume":"6","author":"Jagtap","year":"2021","journal-title":"IP Arch Cytol Histopathol Res"},{"key":"R14-13-20240828","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4103\/ijo.IJO_3763_20","article-title":"COVID-19 and orbital mucormycosis","volume":"69","author":"Sarkar","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R15-13-20240828","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/myc.13135","article-title":"COVID-19 associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia:An observational study from Pakistan","volume":"63","author":"Nasir","year":"2020","journal-title":"Mycoses"},{"key":"R16-13-20240828","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/medicina55070319","article-title":"Invasive and non-invasive fungal rhinosinusitisda review and update of the evidence","volume":"55","author":"Deutsch","year":"2019","journal-title":"Medicina"},{"key":"R17-13-20240828","doi-asserted-by":"crossref","first-page":"17e44","DOI":"10.1093\/jac\/28.suppl_A.13","article-title":"The clinical presentation and diagnosis of invasive fungal infections","volume":"28","author":"Maartens","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"R19-13-20240828","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/dom.14057","article-title":"COVID-19 infection may cause ketosis and ketoacidosis","volume":"22","author":"Li","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"R20-13-20240828","doi-asserted-by":"crossref","first-page":"101597","DOI":"10.1016\/j.bjid.2021.101597","article-title":"Is mucormycosis an inevitable complication of Covid-19 in India?","volume":"25","author":"Bhogireddy","year":"2021","journal-title":"Braz J Infect Dis"},{"key":"R22-13-20240828","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/QCO.0b013e3283165fd1","article-title":"Iron acquisition:A novel perspective on mucormycosis pathogenesis and treatment","volume":"21","author":"Ibrahim","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"R23-13-20240828","first-page":"e10726","article-title":"Rhino-orbital mucormycosis associated with COVID-19","volume":"12","author":"Mehta","year":"2020","journal-title":"Cureus"},{"key":"R24-13-20240828","doi-asserted-by":"crossref","first-page":"100971","DOI":"10.1016\/j.mycmed.2020.100971","article-title":"Invasive fungal diseases during COVID-19:We should be prepared","volume":"30","author":"Gangneux","year":"2020","journal-title":"J Mycol Med"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1599_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:56:05Z","timestamp":1787756165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1599_21"}},"subtitle":["An Inevitable Complication of COVID-19"],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1599_21","relation":{},"ISSN":["2249-4863"],"issn-type":[{"value":"2249-4863","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]}}}